Updated Jul 16, 2026
Hensley Mark Earl has filed 2 SEC Form 4 filings across 1 company in the last 90 days.
Mark Earl Hensley is associated with Heron Therapeutics, Inc., a biopharmaceutical company focused on developing and commercializing innovative products for the treatment of pain and other conditions. Specific details about his role and contributions are limited in public records.
| Role | Insider |
|---|---|
| Notability | 10/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-07 | HRTX | HERON THERAPEUTICS, INC. /DE/ | M — Option exercise | 125.0K | — | |
| 2026-05-04 | HRTX | HERON THERAPEUTICS, INC. /DE/ | M — Option exercise | 11.8K | — |
Mark Earl Hensley is associated with Heron Therapeutics, Inc., a biopharmaceutical company focused on developing and commercializing innovative products for the treatment of pain and other conditions. Specific details about his role and contributions are limited in public records.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Hensley Mark Earl profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.